|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 17, 2017 )
Contrast media are the agents used in the medical imaging techniques for improving the contrast of structures or fluids in the body to help the better image of anatomical structures. Contrast media are commonly used in the various imaging techniques such as Computerized Tomography (CT), X-ray, MRI scans, and ultrasound techniques. The most commonly used contrast media are iodine and gadolinium-containing contrast media.
Increase in the prevalence of cardiovascular, neurological, cancer, and other chronic diseases, rise in technological advancements in contrast media such as syringeless power injectors, and growing usage of MRI, CT, and echocardiogram in diagnosis of various diseases are anticipated to fuel the contrast media market over the forecast period. Moreover, approvals of the novel contrast agents, rise in public-private partnership for establishing diagnostic centres, product pipeline (In May 2016, Dotarem sponsored by Guerbet is in Phase 3 clinical trials), and increase in R&D activities for developing various contrasting agents also expected to boost the contrast media market. However, the adverse effects associated with the contrast media, lower adoption in underdeveloped economies, and lack of reimbursement policies are the factors hinder the growth of contrast media market.
A sample of this report is available upon request @ <||>rnhttps://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/#ulp-4H8Z4LpNMLEuOnnx
Contrast media market is segmented on the basis of product type, imaging technique, route of administration, indication, application, and end user
Based on the product type, contrast media market is segmented into the following:
• Gadolinium-based contrast media
• Iodinated contrast media
• Barium-based contrast media
• Microbubble contrast media
Based on the imaging technique, contrast media market is segmented into the following:
• Ultrasound techniques
• X-ray
• Magnetic resonance imaging (MRI)
• Computerized tomography (CT)
• Others
Based on the route of administration, contrast media market is segmented into the following:
• Oral contrast media
• Rectal contrast media
• Injectable contrast media
• Urethral contrast media
Based on the indication, contrast media market is segmented into the following:
• Oncology
• Neurological disorders
• Cardiovascular disorders
• Gastrointestinal disorders
• Musculoskeletal disorders
• Others
Based on the application, contrast media market is segmented into the following:
• Interventional cardiology
• Interventional radiology
• Radiology
Based on the end user, contrast media market is segmented into the following:
• Hospitals
• Clinics
• Diagnostic centres
• Others
To view TOC of this report is available upon request @ <||>rnhttps://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/#ulp-c654SbFYO64MsOhu
Contrast media market is growing at a significant CAGR owing to increase in the prevalence of chronic diseases and upsurge in the adoption of various diagnostic techniques such as CT, MRI, X-ray and ultrasound in the wide range of applications. Companies are focusing on the R&D activities for the development of newer contrast agents for improving the contrast of the images. Acquisitions and mergers, product approvals, and product launchings are the strategies followed by the companies for increasing their revenue. For instance, in May 2016, FDA approved the Gadavist injection manufactured by Bayer used with magnetic resonance angiography of the supra-aortic artery. Moreover, in 2015, Guerbet has acquired Mallinckrodt’s contrast media and delivery systems for the diversification of business segment.
Need more information about this report @ <||>rnhttps://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/#ulp-14mlyhjMGhVjZqa3
Geographically, contrast media market is segmented into North America, Asia Pacific, Latin America, Europe, and Middle East and Africa. Increase in the R&D activities for the innovation of newer contrast agents and rise in the prevalence of cancer and cardiovascular disorders are driving North America market in global contrast media market. Europe contrast media market is growing at a significant CAGR owing to increase in the adoption of various diagnostic techniques for diagnosis of cancer, neurological, and cardiovascular diseases, launching of newer contrast agents in the Europe region, and increase in healthcare expenditure are the factors driving the contrast media market in the region. Moreover, increase in geriatric population in India, China, and Japan, improving healthcare infrastructure, rise in demand for medical tourism in Asia Pacific region are anticipated to propel the revenue growth of contrast media market in the Asia Pacific region.
Some of the players in contrast media market are GE Healthcare (U.S.), Bayer AG (Germany), Guerbet Group (France), Daiichi Sankyo (Japan), Bracco Imaging S.p.A. (Italy), Medtronic plc. (Ireland), Spago Nanomedical AB (Sweden), nanoPet Pharma GmbH (Germany), and Lantheus Medical Imaging Inc. (U.S.) to name a few.
Get access to full summary @ <||>rnhttps://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Precision Business Insights
Sales
+1-866-598-1553
sales@precisionbusinessinsights.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
